PCG
58
5
EL
17
5
HSY
34
3
AMG
50
4
SIG
40
2
STI
21
11
ADI
41
3
AMP
49
3
IVZ
18
3
DOV
56
6
ADP
65
6
WMT
66
4
JNPR
63
4
VMC
57
4
BLK
55
6
WDC
36
3
MAS
56
2
LLY
45
6
SRE
45
7
MCD
57
2
PCG
58
5
EL
17
5
HSY
34
3
AMG
50
4
SIG
40
2
STI
21
11
ADI
41
3
AMP
49
3
IVZ
18
3
DOV
56
6
ADP
65
6
WMT
66
4
JNPR
63
4
VMC
57
4
BLK
55
6
WDC
36
3
MAS
56
2
LLY
45
6
SRE
45
7
MCD
57
2
Financhill
Back

Novo Nordisk AS Stock Predictions

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

NONOF
Novo Nordisk AS

Last Price:
$64.44
Seasonality Move:
3.8%

7 Day Trial

ALL ACCESS PASS

$ 7

[Urgent Alert] This unique trade could land you 100% gains in 10 days

Discover how much you can make with this "Friday Phenomenon."

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22.4% based on the past 16 years of stock performance.
  • Novo Nordisk AS has risen higher in 14 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NONOF] share price is $64.44. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22.4% based on the past 16 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
30
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 14 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%

Novo Nordisk AS Stock Price History

Is NONOF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
149.55
52-Week Low:
59.75

Prediction Charts

Market Cap:
286.1B
Price in USD:
64.44
Volume:
22.7K
Beta:
0.55

Technical Analysis

SMA50:
78.84
SMA100:
87.29
SMA200:
107.40
52-Wk Change:
-48.4%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 64.44 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 75.38 73.35 75.99 73.35
Mar-26 72.95 71.49 73.91 70.85
Mar-27 69.51 69.78 70.64 69.25
Mar-28 69.78 69.30 70.17 68.03
Mar-31 67.78 68.96 69.50 66.88
Apr-1 69.51 67.56 70.35 67.25
Apr-2 67.96 68.22 68.75 67.34
Apr-3 67.99 67.14 68.68 66.90
Apr-4 64.85 62.16 65.66 61.40
Apr-7 61.29 63.14 64.68 60.67
Apr-8 65.33 62.30 65.33 61.13
Apr-9 60.86 65.00 65.00 59.77
Apr-10 63.45 61.10 63.49 59.75
Apr-11 64.30 64.44 65.00 63.43

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.